Re: J&J Abiraterone going generic

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: J&J Abiraterone going generic

posted on Nov 21, 2018 04:23PM

Zytiga generics looming as US court nixes J&J patent

October 29, 2018

....J&J has said it strongly disagrees with the court’s decision and plans to appeal, but the ruling could open the door to generic versions of Zytiga (abiraterone acetate) – which brought in $1.4bn in revenues from the US in the first nine months of the year and is J&J’s biggest product – as early as 31 October....

https://pharmaphorum.com/news/zytiga-generics-looming-as-us-court-nixes-jj-patent/

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply